Seach Medical Group Ltd Asset Resilience Ratio
Seach Medical Group Ltd asset resilience ratio. Seach Medical Group Ltd (SEMG) has an Asset Resilience Ratio of 17.35% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SEMG days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Seach Medical Group Ltd (2022–2025)
Asset resilience ratio of Seach Medical Group Ltd from 2022 to 2025. This chart shows how Seach Medical Group Ltd's Asset Resilience Ratio has changed over time. Read Seach Medical Group Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Seach Medical Group Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see SEMG asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 0% |
| Short-term Investments | ILA23.91 Million | 17.35% |
| Total Liquid Assets | ILA23.91 Million | 17.35% |
Asset Resilience Insights
- Good Liquidity Position: Seach Medical Group Ltd maintains a healthy 17.35% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Seach Medical Group Ltd Industry Peers by Asset Resilience Ratio
Compare Seach Medical Group Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
Drug Manufacturers - Specialty & Generic | 29.37% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Shenzhen Chipscreen Biosciences Co
SHG:688321 |
Drug Manufacturers - Specialty & Generic | 5.10% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829 |
Drug Manufacturers - Specialty & Generic | 0.00% |
Seach Medical Group Ltd Asset Resilience Ratio by Year (2022–2025)
Seach Medical Group Ltd asset resilience ratio by year from 2022 to 2025. The table below shows the annual Asset Resilience Ratio data for Seach Medical Group Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 14.50% | ILA20.18 Million ≈ $54.09K |
ILA139.13 Million ≈ $373.00K |
+14.40pp |
| 2022-12-31 | 0.10% | ILA166.00K ≈ $445.04 |
ILA161.93 Million ≈ $434.12K |
-- |
About Seach Medical Group Ltd
Seach Medical Group Ltd manufactures and sells medicinal cannabis products worldwide. The company provides cannabis oil and medical cannabis inflorescence products. Seach Medical Group Ltd was incorporated in 1987 and is based in Ramat Gan, Israel.